IP Library Patent Application 16806555
Patent Application
App. No. 16/806,555

STAINING AGENT SOLUTIONS FOR USE IN FLUORESCENCE MICROSCOPY

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/806,555
Abstract

Disclosed herein are staining agent solutions for use in fluorescence microscopy. One example of fluorescence microscopy in which the staining agent solutions are useful is intraoperative confocal microscopy. Intraoperative confocal microscopy can be used, for example, to assess margins of resected cancerous tissue. Example staining agent solutions include acridine orange, where the pH of the solution is from 6 to 8, for example from 6.8 to 7.4. The solution may include a phosphate-buffered saline (PBS). The solution may be isotonic. The solution may comprise one or more of potassium dihydrogen phosphate, disodium hydrogen phosphate, and sodium chloride. In some embodiments, the staining agent solution does not comprise acetic acid (e.g., an acetate buffer). Staining agent solutions disclosed herein may reduce adverse impacts to tissue resulting from staining. Staining agent solutions disclosed herein may preserve normal appearance of tissue. Staining agent solutions disclosed herein may have negligible or reduced odor.

Claims (20)

1 . A staining agent solution for use in fluorescence microscopy, the staining agent solution comprising acridine orange at a concentration from 0.05 g/L to 0.9 g/L, wherein the staining agent solution has a pH from 6 to 8 (e.g., from 6.5 to 7.5).

2 . The staining agent solution of claim 1 , wherein the staining agent solution is a saline solution.

3 . The staining agent solution of claim 1 , the solution comprising a buffer.

4 . The staining agent solution of claim 1 , wherein the buffer is a phosphate-buffered saline (PBS).

5 . The staining agent solution of claim 1 , wherein the solution is isotonic.

6 . The staining agent solution of claim 1 , wherein the solution has a pH of from 6.8 to 7.4.

7 . The staining agent solution of claim 1 , wherein the solution comprises a phosphate-buffered saline (PBS).

8 . The staining agent solution of claim 1 , wherein the acridine orange is acridine orange CAS 65-61-2.

9 . The staining agent solution of claim 1 , wherein the acridine orange is acridine orange CAS 10127-02-3.

10 . The staining agent solution of claim 1 , wherein the concentration of the acridine orange is from 0.18 g/L to 0.22 g/L.

11 . The staining agent solution of claim 1 , the solution comprising sodium chloride.

12 . The staining agent solution of claim 11 , the solution having a sodium chloride concentration of from 6 g/L to 9 g/L.

13 . The staining agent solution of claim 1 , the solution comprising potassium dihydrogen phosphate.

14 . The staining agent solution of claim 13 , wherein the solution has a potassium dihydrogen phosphate concentration of less than 1 g/L.

15 . The staining agent solution of claim 14 , wherein the solution has a potassium dihydrogen phosphate concentration of from 0.2 g/L to 0.6 g/L.

15 . The staining agent solution of claim 1 any one of the preceding claims, the solution comprising disodium hydrogen phosphate.

16 . The staining agent solution of claim 15 , the solution having a disodium hydrogen phosphate concentration of from 1 g/L to 3 g/L.

17 . The staining agent solution of claim 1 , wherein the solution does not comprise acetic acid.

18 - 28 . (canceled)

29 . A staining agent solution for use in fluorescence microscopy, the staining agent solution comprising a fluorophore at a concentration from 0.05 g/L to 0.9 g/L, wherein the solution has a pH of from 6 to 8.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE DOCKET NUMBER PREVIOUSLY RECORDED AT REEL: 73461 FRAME: 559. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Feb 4, 2026
From: SAMANTREE MEDICAL SA
To: SAMANTREE MEDICAL (SWITZERLAND) SA
Reel/Frame 074603/0244 →
CHANGE OF NAME Recorded Jan 14, 2026
From: SAMANTREE MEDICAL SA
To: SAMANTREE MEDICAL (SWITZERLAND) SA
Reel/Frame 073461/0559 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 8, 2020
From: SHAFFER, ETIENNE; HORISBERGER, AURÈLE TIMOTHÉE; SCHMITT, FRÉDÉRIC; RACHET, BASTIEN
To: SAMANTREE MEDICAL SA
Reel/Frame 052613/0878 →